Citation Impact
Citing Papers
Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
2002 StandoutScience
Differential Effects of 5-HTTLPR Genotypes on the Behavioral and Neural Responses to Tryptophan Depletion in Patients With Major Depression and Controls
2006
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
In vivo detection of short- and long-term MDMA neurotoxicity?a positron emission tomography study in the living baboon brain
1998
Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]β-CIT SPECT study – preliminary report
2001
Neuroreceptor imaging in psychiatric disorders
2002
Progressive supranuclear palsy: where are we now?
2002
Parkinson's disease: clinical features and diagnosis
2008 Standout
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
2010
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Stages in the development of Parkinson’s disease-related pathology
2004 Standout
Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers
2001
Epidemiology of Parkinson's disease
2006 Standout
In vivo imaging of synaptic function in the central nervous system
2009
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Reduced Central Serotonin Transporters in Alcoholism
1998
Parkinson's disease
2009 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Occupancy of Serotonin Transporters by Paroxetine and Citalopram During Treatment of Depression: A [11C]DASB PET Imaging Study
2001
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
2004 Standout
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
2012 Standout
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
2002
Parkinson's disease
2015 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders
2003
Accuracy of clinical diagnosis of progressive supranuclear palsy
2003
Basal ganglia cholinergic and dopaminergic function in progressive supranuclear palsy
2007
Neurochemical brain imaging investigations of schizophrenia
1999
Neuroimaging studies of mood disorders
2000
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity
2000
Autonomic dysfunction in movement disorders
2001
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Reducedin vivobinding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users
1999
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
2008 Standout
Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons
2001
Major Depressive Disorder
2008 Standout
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Low cerebrovascular reserve capacity in long-term follow-up after subarachnoid hemorrhage
2005
Non-motor features of Parkinson disease
2017 Standout
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
1998
Measuring the progression of idiopathic Parkinson's disease with [ 123 I] β-CIT SPECT
2000
A systematic review of prevalence studies of dementia in Parkinson's disease
2005 Standout
Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour
1997
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
2007 Standout
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
How to diagnose multiple system atrophy
2005
In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice
2004
Criteria for the diagnosis of corticobasal degeneration
2013 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
2006 StandoutScience
Preclinical (premotor) Parkinson’s disease
2000
MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective
2016
Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts
2014
Imaging neurochemical endophenotypes: promises and pitfalls
2001
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
The prevalence of Parkinson's disease: A systematic review and meta‐analysis
2014 Standout
Dopamine reuptake site densities in patients with social phobia
1997
Works of T. Br�cke being referenced
SPECT imaging of dopamine receptors with [123I]epidepride: characterization of uptake in the human brain
1995
?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo
1995
A study of acetazolamide-induced changes in cerebral blood flow using99mTc HMPAO SPECT in patients with cerebrovascular disease
1995
[123I]?-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration
2000
IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol
1997
SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain
1993